These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1803451)

  • 21. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
    Boyce NW; Holdsworth SR
    J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis.
    Rovin BH; Rumancik M; Tan L; Dickerson J
    Lab Invest; 1994 Oct; 71(4):536-42. PubMed ID: 7967509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor.
    Kanamaru Y; Arcos-Fajardo M; Moura IC; Tsuge T; Cohen H; Essig M; Vrtovsnik F; Loirat C; Peuchmaur M; Beaudoin L; Launay P; Lehuen A; Blank U; Monteiro RC
    Eur J Immunol; 2007 Apr; 37(4):1116-28. PubMed ID: 17393381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of rheumatoid factor with immune complexes in experimental glomerulonephritis--possible role of antiglobulins in chronicity.
    Ford PM
    J Rheumatol Suppl; 1983 Dec; 11():81-4. PubMed ID: 6230448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunopathogenic mechanisms in glomerulonephritis].
    Amoroso A; Cavarretta LM; De Rosa FG; Ferri GM
    Riv Eur Sci Med Farmacol; 1995; 17(4):133-40. PubMed ID: 8545567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A model of in situ immune complex glomerulonephritis in the rat employing cationized ferritin.
    Batsford SR; Takamiya M; Vogt A
    Clin Nephrol; 1980 Nov; 14(5):211-6. PubMed ID: 7014052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.
    Camussi G; Pawlowski I; Saunders R; Brentjens J; Andres G
    J Lab Clin Med; 1987 Aug; 110(2):196-206. PubMed ID: 2955066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody analysis of glomerular hypercellularity in human glomerulonephritis.
    Hooke DH; Hancock WW; Gee DC; Kraft N; Atkins RC
    Clin Nephrol; 1984 Oct; 22(4):163-8. PubMed ID: 6391767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New advances in understanding the treatment of glomerulonephritis.
    Lockwood CM
    Clin Nephrol; 1986; 26 Suppl 1():S76-80. PubMed ID: 3829472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental autoimmune glomerulonephritis in chickens.
    Bolton WK; Tucker FL; Sturgill BC
    J Clin Lab Immunol; 1980 May; 3(3):179-84. PubMed ID: 7420406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathogenesis and therapy of glomerulonephritis. Reflections on recent advances].
    Andres G
    Recenti Prog Med; 1992 Mar; 83(3):160-77. PubMed ID: 1585037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glomerulonephritis, Th1 and Th2: what's new?
    Tipping PG; Kitching AR
    Clin Exp Immunol; 2005 Nov; 142(2):207-15. PubMed ID: 16232206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibasement membrane disease. I. The glomerular lesions of Goodpasture's disease and experimental disease in sheep.
    Germuth FG; Choi IJ; Taylor JJ; Rodriguez E
    Johns Hopkins Med J; 1972 Nov; 131(5):367-84. PubMed ID: 5087173
    [No Abstract]   [Full Text] [Related]  

  • 35. Demonstration of a passive Heymann nephritis-like mechanism in a human kidney transplant.
    Zanetti M; Mandet C; Duboust A; Bedrossian J; Bariety J
    Clin Nephrol; 1981 May; 15(5):272-7. PubMed ID: 7018774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental glomerulonephritis.
    Kondo Y
    Acta Pathol Jpn; 1982; 32 Suppl 1():197-209. PubMed ID: 6764998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrotoxic nephritis and glomerulonephritis: animal model versus human disease.
    Muhammad S
    Br J Biomed Sci; 2014; 71(4):168-71. PubMed ID: 25562994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The importance of inflammatory mediators in immune injury of renal glomeruli].
    Hruby Z
    Postepy Hig Med Dosw; 1992; 46(6):609-25. PubMed ID: 1308581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-Examining Neutrophil Participation in GN.
    Caster DJ; Powell DW; Miralda I; Ward RA; McLeish KR
    J Am Soc Nephrol; 2017 Aug; 28(8):2275-2289. PubMed ID: 28620081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunopathology of glomerulonephritis].
    Erdmann G
    Monatsschr Kinderheilkd (1902); 1969 Apr; 117(4):351-5. PubMed ID: 5377546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.